129 related articles for article (PubMed ID: 19188146)
1. Functional B7.2 and B7-H2 molecules on myeloma cells are associated with a growth advantage.
Yamashita T; Tamura H; Satoh C; Shinya E; Takahashi H; Chen L; Kondo A; Tsuji T; Dan K; Ogata K
Clin Cancer Res; 2009 Feb; 15(3):770-7. PubMed ID: 19188146
[TBL] [Abstract][Full Text] [Related]
2. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
Tamura H; Dan K; Tamada K; Nakamura K; Shioi Y; Hyodo H; Wang SD; Dong H; Chen L; Ogata K
Clin Cancer Res; 2005 Aug; 11(16):5708-17. PubMed ID: 16115907
[TBL] [Abstract][Full Text] [Related]
3. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
Tarte K; Zhang XG; Legouffe E; Hertog C; Mehtali M; Rossi JF; Klein B
J Immunol; 1999 Jul; 163(1):514-24. PubMed ID: 10384156
[TBL] [Abstract][Full Text] [Related]
4. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
Lu ZY; Condomines M; Tarte K; Nadal L; Delteil MC; Rossi JF; Ferrand C; Klein B
Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825
[TBL] [Abstract][Full Text] [Related]
5. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
[TBL] [Abstract][Full Text] [Related]
6. Homing mechanisms in the biology of multiple myeloma.
Van Camp B; Van Riet I
Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
[TBL] [Abstract][Full Text] [Related]
7. The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system.
Qian X; Agematsu K; Freeman GJ; Tagawa Y; Sugane K; Hayashi T
Eur J Immunol; 2006 Apr; 36(4):906-18. PubMed ID: 16552709
[TBL] [Abstract][Full Text] [Related]
8. A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients.
Kuranda K; Berthon C; Dupont C; Wolowiec D; Leleu X; Polakowska R; Jouy N; Quesnel B
Exp Hematol; 2010 Feb; 38(2):124-31. PubMed ID: 19948206
[TBL] [Abstract][Full Text] [Related]
9. Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.
Tamura H; Ishibashi M; Yamashita T; Tanosaki S; Okuyama N; Kondo A; Hyodo H; Shinya E; Takahashi H; Dong H; Tamada K; Chen L; Dan K; Ogata K
Leukemia; 2013 Feb; 27(2):464-72. PubMed ID: 22828443
[TBL] [Abstract][Full Text] [Related]
10. CD28, a marker associated with tumoral expansion in multiple myeloma.
Robillard N; Jego G; Pellat-Deceunynck C; Pineau D; Puthier D; Mellerin MP; Barillé S; Rapp MJ; Harousseau JL; Amiot M; Bataille R
Clin Cancer Res; 1998 Jun; 4(6):1521-6. PubMed ID: 9626472
[TBL] [Abstract][Full Text] [Related]
11. A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment.
Sekimoto E; Ozaki S; Ohshima T; Shibata H; Hashimoto T; Abe M; Kimura N; Hattori K; Kawai S; Kinoshita Y; Yamada-Okabe H; Tsuchiya M; Matsumoto T
Cancer Res; 2007 Feb; 67(3):1184-92. PubMed ID: 17283154
[TBL] [Abstract][Full Text] [Related]
12. The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans.
Salih HR; Wintterle S; Krusch M; Kroner A; Huang YH; Chen L; Wiendl H
Exp Hematol; 2006 Jul; 34(7):888-94. PubMed ID: 16797416
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
[TBL] [Abstract][Full Text] [Related]
14. Synergistic costimulation by both B7 molecules regulates colitis pathogenesis.
Kim G; Schoenberger SP; Sharpe A; Kronenberg M
Ann N Y Acad Sci; 2006 Aug; 1072():233-41. PubMed ID: 17057203
[TBL] [Abstract][Full Text] [Related]
15. Lack of B7 expression, not human leukocyte antigen expression, facilitates immune evasion by human malignant gliomas.
Anderson RC; Anderson DE; Elder JB; Brown MD; Mandigo CE; Parsa AT; Goodman RR; McKhann GM; Sisti MB; Bruce JN
Neurosurgery; 2007 Jun; 60(6):1129-36; discussion 1136. PubMed ID: 17538388
[TBL] [Abstract][Full Text] [Related]
16. Immune accessory functions of human endothelial cells are modulated by overexpression of B7-H1 (PDL1).
LaGier AJ; Pober JS
Hum Immunol; 2006 Aug; 67(8):568-78. PubMed ID: 16916652
[TBL] [Abstract][Full Text] [Related]
17. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity.
Wong SC; Tan AH; Lam KP
Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753
[TBL] [Abstract][Full Text] [Related]
18. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
[TBL] [Abstract][Full Text] [Related]
19. Preclinical development of hybrid cell vaccines for multiple myeloma.
Walewska R; Teobald I; Dunnion D; Abdulmajed H; Aldred M; Sadler J; Chapman C; Browning M
Eur J Haematol; 2007 Jan; 78(1):11-20. PubMed ID: 17302859
[TBL] [Abstract][Full Text] [Related]
20. Human bone marrow stroma-dependent myeloma sister cell lines MOLP-6 and MOLP-7 derived from a patient with multiple myeloma.
Harashima A; Matsuo Y; Nishizaki C; Kozuka T; Fukuda S; Sezaki T; Orita K
Hum Cell; 2000 Mar; 13(1):43-54. PubMed ID: 10937346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
